from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0818/-

LFCtreatmentdescriptionclass of inhibitor

-0.365

Amikacinug/mL Amikacintranslation

0.246

Cap5-10ug/mL Capreomycintranslation

0.615

Rox10-50 ug/mL Roxithromycintranslation

-0.292

SM2-5 ug/mL Streptomycintranslation

0.866

Tet5-10 ug/mL Tetracyclinetranslation

-0.497

Rif0.2-5ug/mL Rifampicintranscription

-0.915

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.304

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.416

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.098

CPZ10-50 ug/mL Chlorpromazinerespiration

0.052

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.217

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.145

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.102

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.840

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.151

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.745

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.872

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.213

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.081

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.699

KCN5-20 ug/mL Potassium cyaniderespiration

1.365

NaN30.2-2 mM Sodium aziderespiration

-0.296

Nigericin50 uM Nigericinrespiration

-0.221

TRC10-150 ug/mL Triclosanrespiration

-0.962

TRZ10-25 ug/mL Thioridazinerespiration

1.173

Valinomycin0.5-10 uM Valinomycinrespiration

-0.679

ZnSO42 mM ZnSO4respiration

0.302

menadione6-10 ug/mL Menadionerespiration

-0.206

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.505

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.467

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.568

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.207

NRP_1Non-replicating persistence stage 1dosRassociated

-0.572

Amp0.2mg/mL AmpicillincellWall

-0.734

Cephalexin20-100 ug/mL CephalexincellWall

0.017

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.827

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.399

EMB10-20 ug/mL EthambutolcellWall

-0.078

Eta12-40 ug/mL EthionamidecellWall

-0.051

INH0.2-0.4 ug/mL IsoniazidcellWall

0.215

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.111

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.874

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.356

BZA0.12 mg/mL BenzamidearomaticAmides

0.543

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.289

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.038

H2O24 mM hydrogen peroxideDNAdamaging

-0.280

Levo10 ug/mL LevofloxacinDNAdamaging

-0.403

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.253

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.094

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.154

UVUV-irradiationDNAdamaging

-1.171

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.447

Antimycin12.5-50 ug/mL Antimycin A?

-0.372

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.700

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.010

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.705

PA8240.2-2 ug/mL PA-824?

2.121

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.551

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.124

Verapamil50 uM Verapamil?

-0.377

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.420

methoxatin10-20 ug/mL Methoxatin?